Blue light cystoscopy with hexaminolevulinate can be an easily replicable procedure in patients with non–muscle-invasive bladder cancer.

On this podcast, Angela B. Smith, MD, MS, discusses the recent FDA approval of Jelmyto for the treatment of low-grade upper tract urothelial cancer.